Connor, Clark & Lunn Investment Management »

BioCryst Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2013-12-31 $2.6M 317k 8.08
2013-06-30 $183k 112k 1.64